Yahoo
NasdaqCM - Nasdaq Real Time Price USD

Enveric Biosciences, Inc. (ENVB)

1.4240 +0.0040 (+0.28%)
At close: November 6 at 4:00:00 PM EST
1.4200 +0.0100 (+0.71%)
Overnight: 2:13:58 AM EST
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements have been upgraded
A new layout with more detail in every statement.
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
0 0 0 0 0
Selling, General and Administrative Expenses
-6,098.8560 -5,792.5730 -6,453.5050 -10,700.2560 -11,605.7610
Research and Development Expenses
-2,475.7010 -2,781.0170 -2,841.2720 -7,252.4370 -8,027.7730
Depreciation, Amortization and Depletion
-153.9200 -200.8580 -337.4890 -343.9820 -327.9100
Operating Income/Expenses
-8,728.4770 -8,774.4480 -9,632.2660 -18,296.6750 -19,961.4440
Total Operating Profit/Loss
-8,728.4770 -8,774.4480 -9,632.2660 -18,296.6750 -19,961.4440
Total Net Finance Income/Expense
-0.5710 -0.1060 0.2190 3.7080 -5.2490
Net Investment Income
45.9900 -- 45.9900 1,030.1480 7,462.9620
Irregular Income/Expenses
-- -- -- 0 -7,453.6620
Other Income/Expense, Non-Operating
0.0020 2.5670 65.9900 0 --
Non-Operating Income/Expenses, Total
-0.5690 2.4610 66.2090 1,033.8560 4.0510
Pretax Income
-8,729.0460 -8,771.9870 -9,566.0570 -17,262.8190 -19,957.3930
Provision for Income Tax
0 0 -8.9300 -28.9130 1,486.0600
Net Income from Continuing Operations
-8,729.0460 -8,771.9870 -9,574.9870 -17,291.7320 -18,471.3330
Net Income after Extraordinary Items and Discontinued Operations
-8,729.0460 -8,771.9870 -9,574.9870 -17,291.7320 -18,471.3330
Non-Controlling/Minority Interests
0 -- 0 -19.0410 -33.0140
Net Income after Non-Controlling/Minority Interests
-8,729.0460 -8,771.9870 -9,574.9870 -17,310.7730 -18,504.3470
Preferred/Other Stock Distribution
-1,513.4490 -- 0 -147.9880 -295.9760
Other Adjustments to Net Income Available to Common Stockholders
-3,359.4850 -3,359.4850 0 -- --
Net Income Available to Common Stockholders
-12,088.5310 -12,131.4720 -9,574.9870 -17,458.7610 -18,800.3230
Diluted Net Income Available to Common Stockholders
-12,088.5310 -12,131.4720 -9,574.9870 -17,458.7610 -18,800.3230
Basic EPS
-13.01 -36.24 -228.48 -1.46k -2.34k
Diluted EPS
-13.01 -36.24 -228.48 -1.46k -2.34k
Basic Weighted Average Shares Outstanding
334.7190 334.7190 41.9080 11.9950 8.0330
Diluted Weighted Average Shares Outstanding
334.7190 334.7190 41.9080 11.9950 8.0330
Income Statement, Supplemental
EBIT
-8,728.4750 -8,771.8810 -9,566.2760 -17,266.5270 -19,952.1440
EBITDA
-8,574.5550 -8,571.0230 -9,228.7870 -16,858.4970 -19,516.9430
Normalized EBITDA
-7,933.5530 -7,746.2650 -7,712.3850 -15,742.6910 -9,451.9100
Normalized Income
-8,088.0440 -7,947.2290 -8,377.0294 -16,410.2453 -8,600.7479
12/31/2022 - 5/4/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: